An antiviral treatment under development by Atea Pharmaceuticals is showing promise against Covid-19.
Spatial biology is among the smaller segments of the broader life sciences market. In GEN’s first-ever top-10 A-List for spatial biology biology there are five of...
The Delta variant has demonstrated a likely course for our COVID future – a new endemic piece of the global human microbiome puzzle. It’s not the...
Moderna will construct a state-of-the-art manufacturing facility in Canada in order to provide direct access to mRNA vaccines for the Covid-19 pandemic, as well as future viral threats and...
SARS-Cov-2 has experienced roughly the same amount of evolutionary change during the pandemic as humans have since Homo habilis first walked the Earth about 2.5m years...
Two Vaccine Doses? Why Not Three? Authored by Ethan Yang via The American Institute for Economic Research, On July 28, CNN reported that Pfizer, one of the primary...
The emerging variants of SARS-CoV-2 have illustrated the need for diagnostics that provide quick detection and can be deployed in different types of settings—from hospitals to...
With health concerns on the rise, should you be checking out these health care stocks? The post 4 Health Care Stocks For Your August 2021 Watchlist...
Machine learning is great at finding patterns but doesn’t know what those patterns mean. Combine it with knowledge gained from genetic research and you have a...
In a review of recently published scientific studies, investigators at Keck School of Medicine of USC identified a natural barrier to the inner’s sensory cells’ ability to...
The three best stocks to buy in August have a lot of upside no matter how the stock market at-large is performing overall. The post Top...
In this webinar from GEN, The CRISPR Journal, and sponsored by TriLink, Professor Dan Peer will discuss the state of RNA-based therapeutics, particularly developing a self-assembled...
Investors could be shifting their focus to biotech stocks, should you do the same? The post 4 Biotech Stocks For Your August 2021 Watchlist appeared first...
Shares of Autolus Therapeutics were up in trading after the company announced an exclusive licensing agreement with Moderna to develop new messenger RNA therapeutics for cancer.
The COVID-19 pandemic has jumpstarted innovations in viral detection technologies from electrical-based assays to saliva sampling. The post Methods to Detect Viruses Get a Boost, Thanks...
The teams at Roche and Genentech are off and running at the FDA, with regulators accepting a quick pitch for what would be the first bispecific...
Toronto-based biotech Deep Genomics landed $180 million in the company's oversubscribed Series C.
Vaccines can’t provide 100% protection, so it’s not a failure or surprise when some vaccinated people get sick with COVID-19. The good news is their cases...
When three companies emerged in the winter of 2020 promising that a fancy new technology called mRNA could pull the world out of a deadly pandemic,...
Why Is The CDC Quietly Abandoning The PCR Test For COVID? We have detailed (most recently here and here) the controversy surrounding America's COVID "casedemic" and...
The U.S. FDA approved AstraZeneca's convenient once-a-week glucose-lowering drug Bydureon for 10- to 17-year-olds with type 2 diabetes. According to a study conducted in Canada, one...
People who develop severe COVID-19 have markedly blunted antiviral responses in the nasopharynx Credit: BioRxiv Feb 20, 2021, https://doi.org/10.1101/2021.02.20.431155 The body’s first encounter with SARS-CoV-2, the...
What are the top NASDAQ genetics stocks year-to-date? We run through the five biggest gainers so far this year. The post Top NASDAQ Genetics Stocks appeared...
Novartis has revealed that the FDA has accepted its resubmission for cholesterol-lowering drug Leqvio – rejected unexpectedly by The post Novartis eyes New Year verdict from...
In a roundup of scientific studies on the novel coronavirus, a small study suggests no traces of mRNA vaccines end up in mothers' breast milk and...
Could this exciting frontier of the biotech industry be worth jumping on now? The post 5 Top Synthetic Biology Stocks To Watch This Week appeared first...
Scientists collaborate to model the complex protein responsible for SARS-CoV-2 replication, revealing its potential weak spots for drug development Credit: Greg Hura/Berkeley Lab In February 2020,...
New report published by MDC and CPI The post Complex Medicines: A multi-billion-pound addition to the UK life sciences industry appeared first on .
Experts in viral immunology, ethics and computational biology share their thoughts on England sloughing off the last of the COVID restrictions.
The U.S. Food and Drug Administration approved Merck's Vaxneuvance (Pneumococcal 15-valent Conjugate Vaccine) for active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae...